Platelet serotonin and [3H]paroxetine binding correlate with recurrence of suicidal behavior.
To distinguish state- from trait-dependent associations between serotonergic function and suicidal behavior, platelet serotonergic measures were repeatedly measured, during a 1-year follow-up, in 106 patients who had recently attempted suicide for at least a second time. A major DSM-III-R axis I diagnosis or use of antidepressants were reasons for exclusion. A higher affinity constant (KD) of platelet [3H]paroxetine binding was related to a higher risk of short-term recurrence of a suicide attempt, suggesting a state relationship. Higher levels of platelet serotonin at baseline were a significant predictor of a recurrent suicide attempt within the year of follow-up, suggesting a trait relationship. These associations held equally within the subgroup of 73 patients with a borderline personality disorder. Neither the maximum number of binding sites (Bmax) of [3H]paroxetine nor platelet monoamine oxidase activity correlated with suicidality. The observed association between indicators of platelet serotonin uptake and suicidal behavior suggests a state- and trait-dependency between suicidality and central serotonergic dysfunction.
Verkes
R J
RJ
Department of Psychiatry, Leiden University Hospital, The Netherlands.
Fekkes
D
D
Zwinderman
A H
AH
Hengeveld
M W
MW
Van der Mast
R C
RC
Tuyl
J P
JP
Kerkhof
A J
AJ
Van Kempen
G M
GM
D000293:Adolescent; D000328:Adult; D000368:Aged; D001792:Blood Platelets / Q000378:metabolism*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D017374:Paroxetine / Q000378:metabolism*; D012008:Recurrence; D012701:Serotonin / Q000097:blood*; D013406:Suicide, Attempted; D014316:Tritium
D014316:Tritium; D012701:Serotonin; D017374:Paroxetine